ARPA-H: High-risk, high-reward health research is the mandate of new, billion-dollar US agency

If ARPA-H wants to achieve the success of its predecessor, it will need to operate differently from NIH and NSF, writes Tong Sun, assistant dean of translational health sciences, School of Medicine, University of Washington.